Scopelianos Angelo 4

Accession 0000805928-23-000024

CIK 0000805928other

View on SEC.gov Company Profile

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 6:27 PM ET

Size

24.3 KB

Accession

0000805928-23-000024

Insider Transaction Report

Form 4

Period: 2023-03-16

Axogen, Inc.AXGN

Scopelianos Angelo

VP Research & Development

Transactions

Exercise/Conversion
Common Stock
2023-03-16+2,500→ 39,708 total
Exercise/Conversion
Restricted Stock Units
2023-03-16−3,000→ 3,000 total
→ Common Stock (3,000 underlying)
Exercise/Conversion
Restricted Stock Units
2023-03-16−2,500→ 2,500 total
→ Common Stock (2,500 underlying)
Tax Payment
Common Stock
2023-03-16$8.27/sh−778$6,434→ 36,734 total
Award
Restricted Stock Units
2023-03-16+54,100→ 54,100 total
→ Common Stock (54,100 underlying)
Tax Payment
Common Stock
2023-03-16$8.27/sh−933$7,716→ 35,801 total
Award
Employee Stock Option (right to purchase)
2023-03-16+78,000→ 78,000 total
Exercise: $8.27Exp: 2033-03-16→ Common Stock (78,000 underlying)
Exercise/Conversion
Restricted Stock Units
2023-03-16−8,250→ 8,250 total
→ Common Stock (8,250 underlying)
Exercise/Conversion
Common Stock
2023-03-16+3,000→ 37,208 total
Exercise/Conversion
Common Stock
2023-03-16+8,250→ 34,208 total
Tax Payment
Common Stock
2023-03-16$8.27/sh−2,196$18,161→ 37,512 total

Footnotes (7)

[F1]This reflects the number of restricted stock units that became vested as of March 16, 2023.
[F2]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
[F3]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
[F4]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2025 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2023, 25% of the aggregate shares vest on March 16, 2024, and 25% of the aggregate shares vest on March 16, 2025. Vested shares will be delivered to the reporting person upon the vesting date.
[F5]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
[F6]All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2027 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2025 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.
[F7]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2027 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2025 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.

Documents

1 file

4
wf-form4_167935121279855.xmlPrimary
FORM 4

Issuer

Axogen, Inc.

CIK 0000805928

→

Entity typeother

Related Parties

filerCIK 0001751541

Filing Metadata

Form type: 4
Filed: Mar 19, 8:00 PM ET
Accepted: Mar 20, 6:27 PM ET
Size: 24.3 KB

View on SEC.gov